Johns Hopkins Singapore's Gilberto de Lima Lopes On Singapore’s Growing Importance For Phase I Trials: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Government investment in translational medicine and less-rigid regulations on foreign-approved drugs is starting to show returns for Singapore.